|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of sales | |||||
| Gross income | |||||
| Administrative and selling expenses | |||||
| Other operating income | |||||
| Other operating expenses | |||||
| Reversal of impairment / (impairment) of property, plant and equipment and intangible assets net | |||||
| Impairment Reversal (Impairment) of property, plant and equipment and intangible assets | |||||
| Operating income | |||||
| Gain (Loss) on net monetary position | |||||
| Finance income | |||||
| Finance expenses | |||||
| Share of the profit of associates | |||||
| Income from investments in entities measured at fair value | |||||
| Result from investments in entities measured at fair value | |||||
| Gain from bargain purchase | |||||
| Income before income tax | |||||
| Income tax for the year | |||||
| Net gain (loss) for the year | |||||
| Net income for the year | |||||
| Basic and diluted earnings per share (ARS) | |||||
| – Equity holders of the parent | |||||
| – Non-controlling interests | |||||
| Total net income loss for the year | |||||
| Basic earnings per share | |||||
| Diluted earnings per share | |||||
Loading...